Ivona Butorac Ahel
Research Subjects
Ivona Butorac Ahel has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Goran Palčevski
Clinical Hospital Center Rijeka
3 shared publications - Kristina Baraba Dekanić
Department of Pediatrics, Clinical Hospital Center Rijeka, 51000 Rijeka, Croatia
3 shared publications - Ana Milardović
Department of Pediatrics, School of Medicine, University of Rijeka, 51000 Rijeka, Croatia
2 shared publications - Kristina Lah Tomulić
Klinički bolnički centar Rijeka, Medicinski fakultet Sveučilišta u Rijeci
2 shared publications - Arijan Verbić
Klinika za pedijatriju, KBC Rijeka, Rijeka
1 shared publication - Ilarja Serini Šeremet
Klinički bolnički centar Rijeka, Medicinski fakultet Sveučilišta u Rijeci
1 shared publication
Latest Publications
- Open Access
- 1 June 2026
- Published by Croatian Medical Association in Paediatria Croatica
- Vol. 70 (2) , 125-8
Insulin degludec-related suicide attempt in a non-diabetic adolescent: a case report
Aim: Although insulin is considered a life-saving medication for patients with type 1 diabetes and some patients with type 2 diabetes, there are instances where it is used in suicide attempts. It can cause refractory and prolonged hypoglycemia, which can be challenging for clinicians. Case presentation: We present a case of a 16-year-old non-diabetic patient who attempted suicide with long-acting insulin degludec and presented with life-threatening hypoglycemia. Conclusion: Exogenous insulin administration should be suspected in severe, unexplained hypoglycemia. The interpretation of insulin and C-peptide levels is a crucial diagnostic component in confirming exogenous insulin administration.
- 1 June 2026
- Published by Croatian Medical Association in Paediatria Croatica
- Vol. 70 (2) , 125-8
Open AccessInsulin degludec-related suicide attempt in a non-diabetic adolescent: a case report
Aim: Although insulin is considered a life-saving medication for patients with type 1 diabetes and some patients with type 2 diabetes, there are instances where it is used in suicide attempts. It can cause refractory and prolonged hypoglycemia, which can be challenging for clinicians. Case presentation: We present a case of a 16-year-old non-diabetic patient who attempted suicide with long-acting insulin degludec and presented with life-threatening hypoglycemia. Conclusion: Exogenous insulin administration should be suspected in severe, unexplained hypoglycemia. The interpretation of insulin and C-peptide levels is a crucial diagnostic component in confirming exogenous insulin administration.
- Open Access
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A122-A123
289 Hereditary spherocytosis associated with Gilbert syndrome – a case report
Gilbert syndrome (GS) and hereditary spherocytosis (HS) are hereditary diseases with high prevalence rates and similar symptoms. The calculated coexistence of these two diseases is 15-35/million births. Severe hyperbilirubinemia compared with the degree of hemolysis in patients with HS should raise suspicion of associated clinical conditions such as GS, glucose-6-phosphate-dehydrogenase deficiency or thalassemia. We present the case of a 21-month-old girl with HS and GS. The diagnosis of HS was established by osmotic fragility test results in the age of 40 days. During infancy the patient had several hemolytic episodes precipitated by upper respiratory tract infections, requiring transfusion therapy. Bilirubin levels were around 100 mmol/l. At the age of 21 months during viral infection, an unusually high unconjugated hyperbilirubinemia was noticed (total bilirubin/direct level 239/13 mmol/l) with mild anemia in the absence of severe hemolysis. As hyperbilirubinemia could not be explained by hemolysis, further evaluation was performed. Genotyping of the conjugation enzyme uridine diphosphate-glucuronosyltransferase confirmed GS. The girl has been followed-up regularly, with consistently higher values of total bilirubin. A trial with phenobarbitone resulted in a rapid fall in bilirubin levels (below 34 mmol/l) followed. Our case confirms that the possibility of the coexistence of GS and HS should be considered in patients with inappropriately high serum bilirubin levels when compared with the severity of HS.
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A122-A123
Open Access289 Hereditary spherocytosis associated with Gilbert syndrome – a case report
Gilbert syndrome (GS) and hereditary spherocytosis (HS) are hereditary diseases with high prevalence rates and similar symptoms. The calculated coexistence of these two diseases is 15-35/million births. Severe hyperbilirubinemia compared with the degree of hemolysis in patients with HS should raise suspicion of associated clinical conditions such as GS, glucose-6-phosphate-dehydrogenase deficiency or thalassemia. We present the case of a 21-month-old girl with HS and GS. The diagnosis of HS was established by osmotic fragility test results in the age of 40 days. During infancy the patient had several hemolytic episodes precipitated by upper respiratory tract infections, requiring transfusion therapy. Bilirubin levels were around 100 mmol/l. At the age of 21 months during viral infection, an unusually high unconjugated hyperbilirubinemia was noticed (total bilirubin/direct level 239/13 mmol/l) with mild anemia in the absence of severe hemolysis. As hyperbilirubinemia could not be explained by hemolysis, further evaluation was performed. Genotyping of the conjugation enzyme uridine diphosphate-glucuronosyltransferase confirmed GS. The girl has been followed-up regularly, with consistently higher values of total bilirubin. A trial with phenobarbitone resulted in a rapid fall in bilirubin levels (below 34 mmol/l) followed. Our case confirms that the possibility of the coexistence of GS and HS should be considered in patients with inappropriately high serum bilirubin levels when compared with the severity of HS.
- Open Access
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A116
274 Screening for celiac disease among first-grade pupils using rapid point-of-care test, a prospective study
Celiac disease (CD) is an autoimmune disease triggered by gluten in genetically predisposed individuals with reported global prevalence in children from 0.31% to 0.9%. Despite the increasing prevalence of CD, many patients remain undiagnosed. Several point-of-care tests (POC) for CD have been developed that can be used as useful screening tool. We aimed to determine the prevalence of CD in first-grade pupils in Primorje-Gorski Kotar county, Croatia using POC test. Methods: Biocard celiac test that detects IgA antibodies to tissue transglutaminase in whole blood was used to screen for celiac disease in healthy first-grade children born in 2011 and 2012 who consumed gluten without restrictions. Results: 1478 children were tested and none of them were tested positive with rapid test. In 10 children (0,6%) IgA deficiency has been suspected; only 4 of them agreed to be tested further for total IgA, anti-tTG and anti DGP antibodies. IgA deficiency was confirmed in 3 patients and in all 4 children CD has been excluded. Conclusion: In this, to our knowledge first prospective study in Croatia, we haven’t found children with celiac disease. Further research is needed to establish the true epidemiology of CD in Primorje-Gorski Kotar County and to confirm the value of rapid test in comparison with standard antibody CD testing.
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A116
Open Access274 Screening for celiac disease among first-grade pupils using rapid point-of-care test, a prospective study
Celiac disease (CD) is an autoimmune disease triggered by gluten in genetically predisposed individuals with reported global prevalence in children from 0.31% to 0.9%. Despite the increasing prevalence of CD, many patients remain undiagnosed. Several point-of-care tests (POC) for CD have been developed that can be used as useful screening tool. We aimed to determine the prevalence of CD in first-grade pupils in Primorje-Gorski Kotar county, Croatia using POC test. Methods: Biocard celiac test that detects IgA antibodies to tissue transglutaminase in whole blood was used to screen for celiac disease in healthy first-grade children born in 2011 and 2012 who consumed gluten without restrictions. Results: 1478 children were tested and none of them were tested positive with rapid test. In 10 children (0,6%) IgA deficiency has been suspected; only 4 of them agreed to be tested further for total IgA, anti-tTG and anti DGP antibodies. IgA deficiency was confirmed in 3 patients and in all 4 children CD has been excluded. Conclusion: In this, to our knowledge first prospective study in Croatia, we haven’t found children with celiac disease. Further research is needed to establish the true epidemiology of CD in Primorje-Gorski Kotar County and to confirm the value of rapid test in comparison with standard antibody CD testing.
- Open Access
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A91-A92
217 Hyperosmolar hyperglycemic state in a 7-year-old boy with newly diagnosed type 1 diabetes mellitus
Hyperglycemic hyperosmolar state (HHS) is characterized by severe hyperglycemia and hyperosmolality without significant ketosis and acidosis. Although the incidence of HHS is increasing, it is considerably less frequent in children than diabetic ketoacidosis (DKA). We report a rare case of HHS as the first presentation of type 1 diabetes mellitus (T1DM) in a 7-year-old boy with previously diagnosed Joubert syndrome (JS). He presented to the emergency room with a 3-day history of vomiting. The symptoms of polydipsia and polyuria started several days earlier. On the day of admission he had been drinking an excess of beverages rich in sugars (approximately 800 -900 ml/day). At admission he was tachypnoic, normotensive and moderately dehydrated. It was difficult to assess his mental and neurological status because of JS, but his mother claimed that he was acting normally. Initial biochemistry results demonstrated severe hyperglycemia (115 mmol/l), hyperosmolality of 382 mOsm/kg (effective osmolality 353 mOsm/kg), mild acidosis (venous pH 7.31), hyponatremia (sodium 119 mmol/l; corrected for blood glucose: 138 mmol/L), severe glycosuria, and ketones in urine were negative. The diagnosis of HHS was made and the treatment with intravenous fluid was started and insulin administration begun later. Serum glucose level normalized 20 hours after treatment started. The diagnosis of T1DM was made based on elevated blood antibodies against islet cells (ICA) and islet antigen 2 (IA-2) antibodies. He was discharged after 10 days without any complications related to HHS and is being regularly followed up. Since HHS has high mortality rate, early recognition and proper management are necessary for a better outcome.
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A91-A92
Open Access217 Hyperosmolar hyperglycemic state in a 7-year-old boy with newly diagnosed type 1 diabetes mellitus
Hyperglycemic hyperosmolar state (HHS) is characterized by severe hyperglycemia and hyperosmolality without significant ketosis and acidosis. Although the incidence of HHS is increasing, it is considerably less frequent in children than diabetic ketoacidosis (DKA). We report a rare case of HHS as the first presentation of type 1 diabetes mellitus (T1DM) in a 7-year-old boy with previously diagnosed Joubert syndrome (JS). He presented to the emergency room with a 3-day history of vomiting. The symptoms of polydipsia and polyuria started several days earlier. On the day of admission he had been drinking an excess of beverages rich in sugars (approximately 800 -900 ml/day). At admission he was tachypnoic, normotensive and moderately dehydrated. It was difficult to assess his mental and neurological status because of JS, but his mother claimed that he was acting normally. Initial biochemistry results demonstrated severe hyperglycemia (115 mmol/l), hyperosmolality of 382 mOsm/kg (effective osmolality 353 mOsm/kg), mild acidosis (venous pH 7.31), hyponatremia (sodium 119 mmol/l; corrected for blood glucose: 138 mmol/L), severe glycosuria, and ketones in urine were negative. The diagnosis of HHS was made and the treatment with intravenous fluid was started and insulin administration begun later. Serum glucose level normalized 20 hours after treatment started. The diagnosis of T1DM was made based on elevated blood antibodies against islet cells (ICA) and islet antigen 2 (IA-2) antibodies. He was discharged after 10 days without any complications related to HHS and is being regularly followed up. Since HHS has high mortality rate, early recognition and proper management are necessary for a better outcome.
- Open Access
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A115.2-A116
273 Prevalence of upper gastrointestinal tract endoscopies at the pediatric clinic of the clinical hospital center rijeka from 2007 to 2017
Aim The aim of the study was to determine the frequency of individual indications, total number of esophagogastroduodenoscopies (EGDS) and pathohistological (PH) findings at the Pediatric Clinic, Clinical Hospital Center ( CHC ) Rijeka. The frequency of therapeutic interventions for foreign body extraction, the most common types of ingested objects, the frequency of ingestion of acid and alkalis, and the placement of PEG were also considered. Materials and Methods The medical records of all patients undergoing EGDS from January 2007 to December 2017 were reviewed retrospectively. In the analysis of the obtained data, the reasons for performing EGDS in each patient were recorded. The sample for PH analysis was taken based on the assesment of the physician who performed the examination (pediatric gastroenterologist). Results The total number of examinations performed was 1022. The most common indications for EGDS were: dyspepsia 32% (n =327), abdominal pain 21% (n= 211), and celiac disease 16% (n = 166). The most common endoscopic findings were : gastritis 50% (n =450), normal findings 35% (n = 325) and esophagitis 9% (n= 84). The most common PH findings were: normal 43% (n = 390), gastritis 23% (n=210), and duodenitis 15% (n =133). Of the total number of examinations, endoscopy was therapeutic in 10% (n= 98) of cases. The most common therapeutic indications were: foreign body ingestion 5% (n =51), PEG placement 3% (n= 35), and acid and alkali ingestion 1% (n=12). Conclusion The results obtainted are consistent with those of other studies and may indicate areas for additional education of staff and a starting point for future research on the topic.
- 11 October 2021
- Published by BMJ
- Vol. 106 (Suppl 2) , A115.2-A116
Open Access273 Prevalence of upper gastrointestinal tract endoscopies at the pediatric clinic of the clinical hospital center rijeka from 2007 to 2017
Aim The aim of the study was to determine the frequency of individual indications, total number of esophagogastroduodenoscopies (EGDS) and pathohistological (PH) findings at the Pediatric Clinic, Clinical Hospital Center ( CHC ) Rijeka. The frequency of therapeutic interventions for foreign body extraction, the most common types of ingested objects, the frequency of ingestion of acid and alkalis, and the placement of PEG were also considered. Materials and Methods The medical records of all patients undergoing EGDS from January 2007 to December 2017 were reviewed retrospectively. In the analysis of the obtained data, the reasons for performing EGDS in each patient were recorded. The sample for PH analysis was taken based on the assesment of the physician who performed the examination (pediatric gastroenterologist). Results The total number of examinations performed was 1022. The most common indications for EGDS were: dyspepsia 32% (n =327), abdominal pain 21% (n= 211), and celiac disease 16% (n = 166). The most common endoscopic findings were : gastritis 50% (n =450), normal findings 35% (n = 325) and esophagitis 9% (n= 84). The most common PH findings were: normal 43% (n = 390), gastritis 23% (n=210), and duodenitis 15% (n =133). Of the total number of examinations, endoscopy was therapeutic in 10% (n= 98) of cases. The most common therapeutic indications were: foreign body ingestion 5% (n =51), PEG placement 3% (n= 35), and acid and alkali ingestion 1% (n=12). Conclusion The results obtainted are consistent with those of other studies and may indicate areas for additional education of staff and a starting point for future research on the topic.
- Open Access
- 10 October 2021
- Published by University Clinical Centre Tuzla in Central European Journal of Paediatrics
- Vol. 17 (2) , 124-127
Short Stature – the Tip of the Iceberg of a Serious Illnesses – a Case Report
- 10 October 2021
- Published by University Clinical Centre Tuzla in Central European Journal of Paediatrics
- Vol. 17 (2) , 124-127
Open AccessShort Stature – the Tip of the Iceberg of a Serious Illnesses – a Case Report
- Open Access
- 1 December 2016
- Published by University of Rijeka, Faculty of Medicine in Medicina Fluminensis
- Vol. 52 (4) , 460-466
Paracetamol poisoning in children
Paracetamol is the most commonly used antipyretic and analgesic in children and the association between paracetamol and hepatotoxicity has been well established. With it's widespread use, it became one of the most common pharmaceuticals associated with both unintentional and intentional poisoning and toxicity. Although therapeutic and unintentional overdosage typically occurs in children, hepatic damage or death due to paracetamol poisoning appears to be rare compared to adults. Despite this fact, paracetamol is currently a major and the most common identifiable cause of acute liver failure in children. Therefore, we bring this review article on well established modes of pathophysiologycal mechanisms of liver damage, current diagnostic and treatment concepts of acute paracetamol poisoning, and special overview of acetylcystein as cornerstone of therapy with proven safety and eficacy in children.
- 1 December 2016
- Published by University of Rijeka, Faculty of Medicine in Medicina Fluminensis
- Vol. 52 (4) , 460-466
Open AccessParacetamol poisoning in children
Paracetamol is the most commonly used antipyretic and analgesic in children and the association between paracetamol and hepatotoxicity has been well established. With it's widespread use, it became one of the most common pharmaceuticals associated with both unintentional and intentional poisoning and toxicity. Although therapeutic and unintentional overdosage typically occurs in children, hepatic damage or death due to paracetamol poisoning appears to be rare compared to adults. Despite this fact, paracetamol is currently a major and the most common identifiable cause of acute liver failure in children. Therefore, we bring this review article on well established modes of pathophysiologycal mechanisms of liver damage, current diagnostic and treatment concepts of acute paracetamol poisoning, and special overview of acetylcystein as cornerstone of therapy with proven safety and eficacy in children.